A federal judge in Philadelphia joined his colleagues in the Eastern District of Pennsylvania and held that McNeil Pharmaceuticals is a New Jersey company, thereby preserving the diversity jurisdiction to keep the case in federal court.
The plaintiffs—the parents of an infant who died after ingesting children’s Tylenol that was manufactured by McNeil, a wholly owned subsidiary of Johnson & Johnson—had moved to remand the case to the Philadelphia Court of Common Pleas.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
